Cited by 191Cholesterol and Lipid MetabolismAlzheimer's disease research and treatmentsDrug Transport and Resistance Mechanisms

Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation

Open access
Kim, Woojin Scott, Rahmanto, Aldwin Suryo, Kamili, Alvin, Rye, Kerry-Anne, Guillemin, Gilles J., Gelissen, Ingrid C., Jessup, Wendy, Hill, Andrew F. +1 more·2007·Journal of Biological Chemistry

Abstract

Maintenance of an adequate supply of cholesterol is important for neuronal function, whereas excess cholesterol promotes amyloid precursor protein (APP) cleavage generating toxic amyloid-beta (Abeta) peptides. To gain insights into the pathways that regulate neuronal cholesterol level, we investigated the potential for reconstituted apolipoprotein E (apoE) discs, resembling nascent lipoprotein complexes in the central nervous system, to stimulate neuronal [3H]cholesterol efflux. ApoE discs potently accelerated cholesterol efflux from primary human neurons and cell lines. The process was saturable (17.5 microg of apoE/ml) and was not influenced by APOE genotype. High performance liquid chromatography analysis of cholesterol and cholesterol metabolites effluxed from neurons indicated that <25% of the released cholesterol was modified to polar products (e.g. 24-hydroxycholesterol) that diffuse from neuronal membranes. Thus, most cholesterol (approximately 75%) appeared to be effluxed from neurons in a native state via a transporter pathway. ATP-binding cassette transporters ABCA1, ABCA2, and ABCG1 were detected in neurons and neuroblastoma cell lines and expression of these cDNAs revealed that ABCA1 and ABCG1 stimulated cholesterol efflux to apoE discs. In addition, ABCA1 and ABCG1 expression in Chinese hamster ovary cells that stably express human APP significantly reduced Abeta generation, whereas ABCA2 did not modulate either cholesterol efflux or Abeta generation. These data indicate that ABCA1 and ABCG1 play a significant role in the regulation of neuronal cholesterol efflux to apoE discs and in suppression of APP processing to generate Abeta peptides.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m607831200

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most studies demonstrated that ABCA1 induction decreases the levels of Aβ and CTFβ.

    “Most of studies demonstrated that ABCA1 induction decreases the levels of Aβ and CTFβ (Kim et al., 2007; Koldamova et al., 2003; Sun et al., 2003).”

    From miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression (2012) · cites this paper as Kim et al., 2007

    In “Regulation of Aβ Peptide Generation by ABCG1” (page unavailable), the paper reports that ABCA1 expression reduced Aβ generation by 55% in CHO-APP cells. It does not report a decrease in CTFβ, so it supports only the Aβ portion of the claim. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • ABCA1 induction by LXR agonist decreases Aβ production in various cell lines.

    “ABCA1 induction by liver X receptor (LXR) agonist decreased Aβ production in various cell lines (Kim et al., 2007; Koldamova et al., 2003; Sun et al., 2003).”

    From miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression (2012) · cites this paper as Kim et al., 2007

    The Results section reports that ABCA1 transfection reduced Aβ generation in CHO-APP cells. The Discussion also describes a previous CHO-cell study in which an LXR agonist induced ABCA1 expression and apoA-I inhibited Aβ generation. This paper does not establish that LXR-agonist induction decreased Aβ production across various cell lines. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • LXR agonists TO901317 and GW3965 alter Aβ production in neuronal and non-neuronal cell cultures overexpressing APP.

    “It has been shown that the LXR agonists TO901317 and GW3965 alter amyloid-␤ (A␤) production in neuronal and non-neuronal cell cultures overexpressing amyloid precursor protein (APP)”

    From Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis (2011) · cites this paper as Kim et al., 2007

    The Discussion (page unavailable) reports that TO901317 treatment was associated with reduced Aβ generation in APP-expressing CHO cells, a non-neuronal culture. It does not report GW3965 or show that either agonist alters Aβ production in neuronal cultures. The paper’s own CHO-APP experiments tested ABCG1 and ABCA1 expression, not these agonists. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • In vitro evidence supports a critical role of ABCA1 in Aβ production.

    “Furthermore, several lines of in vitro evidence support the critical role of ABCA1 in A␤ production, although how ABCA1 regulates A␤ production remains to be clarified (Koldamova et al., 2003;Sun et al., 2003;Kim et al., 2007).”

    From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Kim et al., 2007

  • ABCA1 has a critical role in Aβ metabolism and accumulation.

    “Several lines of data strongly support that ABCA1 has a critical role in Aβ metabolism and accumulation.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 6

  1. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., and Simons, K. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6460 -6464
  2. Lund, E. G., Guileyardo, J. M., and Russell, D. W. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 7238 -7243
  3. Lutjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Siden, A., Dicz- falusy, U., and Bjorkhem, I. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 9799 -9804
  4. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993) Science 261, 921-923
  5. Klucken, J., Buchler, C., Orso, E., Kaminski, W. E., Porsch-Ozcurumez, M., Liebisch, G., Kapinsky, M., Diederich, W., Drobnik, W., Dean, M., Allik- mets, R., and Schmitz, G. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 817-822
  6. Wang, L., Schuster, G. U., Hultenby, K., Zhang, Q., Andersson, S., and Gustafsson, J. A. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 13878 -13883

Cited by

Sorted by citations

Authors
Kim, W. S., Rahmanto, A. S., Kamili, A., Rye, K.-A., Guillemin, G. J., Gelissen, I. C., Jessup, W., Hill, A. F., & Garner, B.
Affiliations
  • Neuroscience Research Australia (AU)
  • The Heart Research Institute (AU)
  • St Vincent's Hospital Sydney (AU)
  • UNSW Sydney (AU)
  • The University of Melbourne (AU)
Corresponding author
Garner, Brett
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2007-02
Volume
282
Issue
5
Pages
2851-2861
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2105761603
Cited by
191
References
12
Citations by year
2026: 6 · 2025: 3 · 2024: 9 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 12 · 2019: 8 · 2018: 6 · 2017: 11 · 2016: 7 · 2015: 11 · 2014: 6 · 2013: 12 · 2012: 14
FWCI
11.90
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
  • Research Online (University of Wollongong) (submittedVersion)
  • Figshare (submittedVersion)
Funders
  • Medical Research Council
  • National Health and Medical Research Council (222722, 350810)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
ABCG1, ABCA1, ABCA2, ABC transporters, amyloid-beta production, APP processing, cholesterol efflux, 24S-hydroxycholesterol, neuroblastoma cells, Alzheimer's disease
MeSH terms
ATP Binding Cassette Transporter, Subfamily G, Member 1, Animals, Apolipoproteins E, Brain, Cell Line, Cells, Cultured, Cholesterol, Cricetulus, Cricetinae, Humans, Kinetics, Male, Neurons, Recombinant Proteins, Transfection, Polymerase Chain Reaction, CHO Cells, ATP-Binding Cassette Transporters, Foreskin, ATP Binding Cassette Transporter 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review